abstract: Prostaglandin F 2a (PGF 2a ) plays a critical role in the initiation and process of parturition. Since human labor has been described as an inflammatory event, we investigated the role of PGF 2a in the inflammatory process using cultured human uterine smooth muscle cells (HUSMCs) isolated from term pregnant women as a model. Using a multiplex assay, HUSMCs treated with PGF 2a changed their output of a number of cytokines and chemokines, with a distinct response pattern that differed between HUSMCs isolated from the upper and lower segment region of the uterus. Confirmatory enzyme-linked immunosorbent assays (ELISAs) showed that PGF 2a stimulated increased output of interleukin (IL) 1b, IL6, IL8 (CXCL8) and monocyte chemotactic protein-1 (MCP1, also known as chemokine (c-c motif) ligand 2, CCL2) by HUSMCs isolated from both upper and lower uterine segments. In contrast, PGF 2a inhibited tumor necrosis factor a (TNFa) release by HUMSCs from the lower uterine segment while the output of TNFa was undetectable in the upper segment. Small interfering (si) RNA mediated knockdown of the PGF 2a receptor prevented the changes in cytokine and chemokine output by the HUSMCs. Since the PGF 2a receptor (PTGFR) couples via the Gq protein and subsequently activates the phospholipase C (PLC) and protein kinase C (PKC) signaling pathways, we examined the role of these pathways in PGF 2a modulation of the cytokines. Inhibition of PLC and PKC reversed the effects of PGF 2a . PGF 2a activated multiple signaling pathways including extracellular signal-regulated kinases (ERK) 1/2, phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K), P38, calcineurin/nuclear factor of activated T-cells (NFAT) and NF-kB signaling. Inhibition of ERK reversed PGF 2a -induced IL1b, IL6 and CCL2 output, while inhibition of PI3K blocked the effect of PGF 2a on IL6, CXCL8 and CCL2 output and inhibition of NF-kB reversed PGF 2a -induced IL1b and CCL2 output. NFAT was involved in PGF 2a modulation of CCL2 and TNFa output. In conclusion, our results support a role of PGF 2a in creating an inflammatory environment during the late stage of human pregnancy.
Introduction
progression of labor being involved in all aspects of parturition including ripening of the cervix, membrane rupture and induction of uterine contraction (Lundin-Schiller and Mitchell, 1990; Olson et al., 1995) .
Accumulating evidence demonstrates that human labor is an inflammatory process, characterized by increased leukocyte infiltration into uterine tissues and increased expression and release of numerous cytokines and chemokines, including interleukin 6 (IL 6), IL1, interleukin 8 (also known as chemokine (c-x-c motif) ligand 8, CXCL8) and CCL2 (Goldenberg et al., 2000; Osman et al., 2003) . The increased cytokines and chemokines further promote the recruitment of leukocytes into uterine tissues in a feed-forward fashion thereby creating an 'inflammatory microenvironment' (Kobayashi, 2008; White et al., 2013) . Within the uterus, such inflammatory cascades result in the up-regulation of uterine activation proteins (UAPs), thereby leading to the onset of parturition (Hertelendy et al., 1993; Young et al., 2002) .
It is well known that PGs can serve as pro-inflammatory mediators due to their high expression in inflamed tissues and ability to induce inflammatory symptoms. One such example, prostaglandin F 2a (PGF 2a ), is produced by gestational tissues with high levels observed at parturition (Olson et al., 1995; Fortier et al., 2008; Maddipati et al., 2014) , and has a recognized physiological role in stimulating myometrial contractions. However, increased PGF 2a concentrations observed in the maternal circulation occur early on in, or precede, the labor process (Kinoshita et al., 1977) , suggesting that PGF 2a is involved in additional parturition events besides uterine contraction. We previously reported that PGF 2a may contribute to transformation of the relatively quiescent uterus of gestation, to the powerful contractile uterus of parturition, by up-regulating expression of the UAPs (Xu et al., 2013) . Moreover, PGF 2a can also serve as an inflammatory mediator, for example, in the female reproductive system, PGF 2a induces CCL2 in the ovary (Luo et al., 2011) and CXCL8 in endometrial adenocarcinoma cells (Pollard and Mitchell, 1996) . The PGF 2a signal is mediated by the PGF 2a receptor (PTGFR), which couples to the G protein Gq to activate multiple signaling pathways which include phospholipase C/protein kinase C (PLC/PKC), mitogen activated protein kinase (MAPKs), phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) and calcineurin/nuclear factor of activated T-cells (NFAT) signaling pathways (Sales et al., 2009; Goupil et al., 2010; Kondo et al., 2012) .
Human uterine smooth muscle cells (HUSMCs) isolated from the pregnant uterus synthesize and secrete chemokines and cytokines such as IL1b, IL6, CCL2 and CXCL8 (Hua et al., 2012; Shynlova et al., 2013a) . In addition, HUMSCs demonstrate increased expression of UAPs such as connexin 43(CX43) and cyclo-oxygenase-2 (COX-2, also known as PTGS-2) in response to treatment with PGF 2a (Xu et al., 2013) . Thus, we hypothesize that PGF 2a regulates chemokine and cytokine output in the myometrium during pregnancy, thereby amplifying the inflammatory responses within uterus.
Finally, in the human uterus, the concept of a functional regionalization has been proposed. This suggests that the upper segment (US) displays a relaxed state during gestation to accommodate the growing fetus but at labor contracts to expel the baby, while the lower segment (LS) maintains a state conducive to passage of the fetal head during labor (Luckas and Wray, 2000) . Our previous study demonstrated that PGF 2a -induced changes in UAP abundance differed in HUSMCs isolated from the upper and lower uterine segments, indicating potential differentiation of roles between US and LS in pregnancy and parturition (Xu et al., 2013) . However, some studies show no difference in contractility between US and LS myometrium. The expression pattern of some UAPs such as PTGFR in US and LS during labor is similar (Hay et al., 2010) whereas some other UAPs, for instance, the PGE 2 receptors, PTGER2 and PTGER3, display different expression levels in US and LS (Grigsby et al., 2006) . Thus, investigating the role of PGF 2a in the regulation of cytokine and chemokine output comparing US and LS myometrial cells will expand our knowledge about functional regionalization in the human uterus.
The objectives of the present study are to (i) assess if PGF 2a participates in the regulation of cytokine and chemokine output in the uterus during pregnancy and (ii) define the signaling pathways involved in the PGF 2a mediated regulation of chemokine and cytokine output. Our study will provide insight into the mechanisms of human parturition and indicate new strategies for development of tocolytics.
Materials and Methods

Isolation and culture of HUSMCs
This study was approved by the specialty committee on ethics of biomedicine research, Second Military Medical University, Shanghai, China as well as the Conjoint Health Research Ethics Board, University of Calgary. Written informed consent was obtained from all the patients involved in this study.
Biopsies of LS human myometrium (n ¼ 11) were obtained from pregnant women undergoing elective cesarean section at term (the average gestational age was 38 weeks, with a range of 37 -42 weeks) in Changhai hospital, Shanghai. Among the patients who were recruited in this study, cesarean section was performed due to breech presentation, previous cesarean section, cephalopelvic disproportion or maternal request. Women who had evidence of underlying disease, such as hypertension, diabetes, pre-eclampsia, intrauterine growth restriction, were not included in this study. Biopsies were excised from the middle portion of upper edge of the incision line in the lower uterine segment. HUSMCs from LS were isolated by enzymatic dispersion as described previously (Xu et al., 2011) . Briefly, myometrial pieces were incubated with phenol-red-free Dulbecco's modified Eagles medium (DMEM) containing 1 mg/ml collagenase type II (Invitrogen, Grand Island, NY), and 1 mg/ml deoxyribonuclease I (Invitrogen) at 378C for 45 min. Following filtration by 100 mm cell strainer (Corning), the cell suspension was centrifuged at 600g for 10 min, and the cell pellet resuspended in DMEM containing 10% fetal calf serum (FCS), penicillin (100 U/ml) and streptomycin (100 mg/ml). The cells were then plated into 25-cm 2 flasks and kept at 378C in 5% CO 2 -95% air humidified atmosphere until confluent ( 2 weeks) and all experiments were performed with these cells at passage 2. For the treatment experiments, when the cell density is up to 90% confluence, 0.05% trypsin was used to disperse cells and placed in 6-well plates with DMEM containing 10% FCS. After the cells had grown to 80% confluence, the media was changed to DMEM without FCS. Subsequently, cells were treated with various concentrations of PGF 2a (Sigma-Aldrich, US) in the presence or absence of kinase inhibitors, including PLC inhibitor (U73122), PKC inhibitor (chelerythrine), ERK inhibitor (PD98059), PI3K inhibitor (LY294002), Calcineurin inhibitor (CsA), the blocker of calcineurin and NFAT interaction (Inca-6), NFAT-AP1 complex inhibitor (RA), P38 inhibitor (SB202190) or NFkB inhibitor (PDTC), and incubated for 24 h. The vehicle control was treated with same volume of solvent (ethanol, ≤0.1% v/v). Concentration of the above inhibitors was determined according to the literature (Pollard and Mitchell, 1996) and our previous studies (You et al., 2012; Xu et al., 2015) . All the above inhibitors were purchased from Sigma-Aldrich. Seven paired biopsies from both US and LS uterine segments were collected from pregnant women undergoing elective cesarean sections at term. The upper segment biopsies were all taken from the side opposite the placenta on the anterior or posterior aspect of the upper segment. Palpation and visualization of the uterus determined where the upper segment began, and the decidual layer was dissected away before a small piece of myometrium was grasped with fine forceps and dissected with Iris scissors. Biopsies of LS and US were dispersed and cultured as described above. Cells were cultured to passage 7 and placed in 6-well plates with DMEM containing 10% FCS and 1 × antimycotic (100 units/ml Penicillin g sodium, 100 mg/ml streptomycin sulfate, 0.25 mg/ml amphotericin B) at 378C with 5% CO 2 . Following growth to 80% confluence, cells were serum deprived overnight then treated with various concentration of PGF 2a (10 28 -10 25 M) and incubated for 24 h. After incubation, supernatant and cells were collected. The in vitro characteristics of the cells from upper (US-HUSMCs) and lower (LS-HUSMCs) segments were maintained to at least 10 passages as described previously (Mosher et al., 2013) .
RNA interference
For knockdown of PTGFR, sequence-specific small interfering RNA (siRNA) targeting human PTGFR (sense 5 ′ -GGUGUAUUGGAGUCACAAAtt-3 ′ ; antisense 5
′ -UUUGUGACUCCAAUACACCgc-3 ′ ) was purchased from Santa Cruz, US (sc-44987). The following nonsense siRNA (sense 5
′ -GAAU CUGGGAUGUUAACCAtt-3 ′ ; antisense 5 ′ -UGGUUAACAUCCCAGAU UCtg-3 ′ ) was also provided by Santa Cruz and used as the negative control. Cultured HUSMCs were transfected with PTGFR siRNA or control siRNA using Lipofectamine TM RNAi MAX (Invitrogen) for 6 h, followed by 18 h of incubation with DMEM only. The cells were treated with increasing concentrations of PGF 2a (10 28 -10 25 M) for 24 h.
Multiplexed fluorescent bead-based immunoassays
The multiplex immunoassays built on magnetic beads were custom-designed and obtained from Eve w Technologies (Calgary, Canada). In total, 42 cytokines, chemokines and growth factors were evaluated in the cell supernatants from primary HUSMCs in absence and presence of 10 26 M PGF 2a . The multiplex assay was carried out by the manufacturer Eve w Technologies (Calgary, Canada).
Enzyme-linked immunosorbent assay
The concentrations of IL6, CCL2, CXCL8, IL1b and tumor necrosis factor a (TNFa) in culture media of myometrial cells were determined with specific enzyme-linked immunoassays (R&D Systems, Inc., Minneapolis, MN, USA) according to the manufacturer's instructions.
Western blotting analysis
HUSMCs were harvested in the presence of M-Per lysis buffer (Pierce Biotechnology, US) and the protein extracted following the manufacturer's protocol. Seventy mg protein was separated by SDS (10% w/v)-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes. Subsequently, membranes were incubated with specific antibodies including PTGFR, p65, phospho-p65(ser-529), ERK1/2, phospho-ERK1/2, NFATC1, p38, phospho-p38, PI3K and phospho-PI3K(Tyr508) overnight at 48C. After incubation with a secondary horseradish peroxidase-conjugated antibody, membranes were visualized using enhanced chemiluminescence (Santa Cruz). The intensities of light-emitting bands were detected and quantified using Sygene Bio Image system (Synoptics Ltd, UK). The levels of phospho-PI3K, phospho-p65, phospho-ERK1/2 and phospho-p38 were normalized to the unphosphorylated type of these proteins, while the level of NFATC1 was normalized to b-actin. The information of all antibodies including manufacture, catalog number and dilution is shown in Supplementary Table SI.
Statistics
The results for all protein determinations are presented as the mean + SEM. Data were tested by SPSS software and found to be normally distributed. Data were then analyzed by two-way ANOVA followed by the Least Significant Difference (LSD) multiple comparison method. Significance was achieved at P ≤ 0.05.
Results
PGF 2a regulates output of chemokines and cytokines in US and LS HUSMCs
We first examined the cytokine and chemokine output, in response to PGF 2a treatment, comparing paired US and LS HUSMCs, using a Multiplex assay. One micromolar PGF 2a modulated the secretion of a number of chemokines and cytokines during a 24-h incubation. PGF 2a robustly stimulated granulocyte-macrophage colony stimulating factor (GM-CSF), IL6, interferon (IFN) a, CXCL8 and CCL2 output in both US and LS cells ( Supplementary Fig. S1 ). However, the response pattern of some cytokines differed between US and LS, for example, PGF 2a induced fibroblast growth factor (FGF) 2, IL12 and IL1b in LS-HUSMCs, but inhibited FGF2 and IL12 output, and had no effect on IL1b output by US-HUSMCs. In general, we observed that PGF 2a induced more pro-inflammatory cytokines in the LS-HUSMCs compared with the US-HUSMCs.
To confirm the effect of PGF 2a on cytokines, we used ELISAs, to measure several pro-inflammatory cytokines, whose secretion was stimulated by PGF 2a in both the LS and US cells in the above experiment. As shown in Fig. 1A , PGF 2a (10 28 -10 26 M) treatment for 24 h increased the levels of CCL2, CXCL8 and IL6 in culture media of both LS and US cells in a dose-dependent manner.
The effects of PGF 2a are mediated by PTGFR
To investigate whether the modulation of cytokine output by PGF 2a occurred as a direct effect via its own receptor, we used sequence-specific siRNA targeting PTGFR to knockdown the levels of PTGFR in the cells. The efficiency of interference with for PTGFR siRNA reached about 72% ( Supplementary Fig. S2 ). As shown in Fig. 1B , knockdown of PTGFR reversed the PGF 2a induced up-regulation of CXCL8, CCL2 and IL6 output in both US and LS cells.
The intracellular signaling pathways involved in PGF 2a regulation of cytokine and chemokine output in the LS HUSMCs
We then investigated the signaling pathways involved in PGF 2a regulation of cytokine and chemokine output in human pregnant myometrium.
Considering that the amount of US biopsies was limited, the following study was performed with the LS myometrial cells. Multiplex results showed that PGF 2a stimulated IL1b output but inhibited TNFa output in LS cells. These results were confirmed using ELISA. As shown in Fig. 2 , PGF 2a inhibited TNFa output (Fig. 2C ) but stimulated IL1b output ( Fig. 2A) by the LS cells in a dose-dependent manner, and as expected, PGF 2a stimulated IL6, CXCL8 and CCL2 output (Fig. 2B, D and E). PGF 2a activation of the PTGFR, a G protein coupled receptor, leads to Gq coupling and subsequent activation of downstream signaling pathways which include phospholipase C b (PLCb), and protein kinase C (PKC) (Goupil et al., 2010; Kondo et al., 2012) . To determine the role of these downstream signaling pathways in the PGF 2a -induced modulation of chemokine and cytokine output, we utilized PLC and PKC inhibitors. Inhibition of either PLC with U73122 (10 25 M) or PKC with chelerythrine (10 25 M) blocked the PGF 2a -induced IL1b, IL6, CXCL8, and CCL2 output as well as PGF 2a inhibition of TNF-a output (Fig. 3) . PGF 2a has been shown to activate PI3K, ERK1/2 and P38 signaling pathways (Goupil et al., 2010; Kondo et al., 2012) . We therefore confirmed these effects in LS HUSMCs. As shown in Fig. 4A-C NF-kB, the archetypal inflammatory transcription factor, is known to drive chemokine and cytokine production. PGF 2a (10 26 M) increased the levels of phospho-p65 in time-dependent manner (Fig. 4D) . The NF-kB inhibitor, PDTC (10 25 M), reversed the PGF 2a -induced IL1b and CCL2 output, but not that of IL6, TNFa or CXCL8 (Fig. 5A -E) . Notably, PDTC itself significantly stimulated IL6 (P , 0.01 versus vehicle) and CXCL8 output (P , 0.05 versus vehicle). Stimulation of the Gq/PLC signaling pathway leads to Ca 2+ release from intracellular calcium stores and subsequently activation of the calcineurin/NFAT pathway. Five members of the NFAT family of transcription factors have been isolated: NFATC2 (NF-AT1/p), NFATC1 (NF-AT2), NFATC4 (NF-AT3), NFATC3 (NF-AT4/x) and NFAT5 (TonEBP) (Rao et al., 1997) . Normally, Ca 2+ induces activation of calcineurin which leads to NFAT dephosphorylation. In human myometrium, NFATC1 has been shown to be activated by Ca 2+ signaling (Pont et al., 2012) . As shown in PGF 2a , chemokines and cytokines in myometrium inhibitor, CsA, the robust stimulation of CCL2 output by PGF 2a was reversed (Fig. 6B) . A similar trend was confirmed by the application of Inca-6, a blocker of calcineurin and NFAT interaction, and RA, an inhibitor of NFAT-AP1 complex. PGF 2a -induced suppression of TNFa output was also blocked by CsA, Inca-6 and RA.
Discussion
Human parturition is an inflammatory event characterized by increased communication between uterine chemotactic signals and leukocytes in late gestation, which peaks at parturition and leads to leukocyte invasion of the uterus at every delivery (Zourbas et al., 2001; Tornblom et al., 2005; Golightly et al., 2011; Singh et al., 2011; Gomez-Lopez et al., 2013) . Even though there is an absence of infection, pro-inflammatory cytokines and chemokines are increased in both of preterm and term birth (Romero et al., 1990; Osmers et al., 1995; Young et al., 2002; Esplin et al., 2005) . The invading leukocytes promote a positive feedforward cycle by secreting pro-inflammatory cytokines and chemokines such as IL1b, IL6, CXCL8 and CCL2 that drive PG synthesis (Golightly et al., 2011) . Previous studies mostly consider that an increase in PG concentration induced by cytokines triggers uterine contractility (Young et al., 2002; Keelan et al., 2003) . However, PGF 2a is more than just a potent stimulator of myometrial contraction. PGF 2a has an important signaling role during parturition, aiding in the transformation of the uterus of gestation to the uterus of delivery near the end of pregnancy. In this study, we extend our knowledge regarding the involvement of PGF 2a in parturition by clearly showing it as one of the mediators that promote the establishment of a pro-inflammatory intrauterine environment by stimulation of pro-inflammatory cytokine and chemokine production in myometrium, leading to the initiation of labor. In this sense, the circle becomes complete; pro-inflammatory cytokines promote synthesis of PGF 2a and its receptor, PTGFR, and PGF 2a promotes cytokine and chemokine synthesis via its receptor.
A number of studies have demonstrated that the rise of IL1b and IL6 in gestational tissues, amniotic fluid and maternal blood prior to labor indicates a role in parturition (Romero et al., 1990; Osman et al., 2003; Shynlova et al., 2013b; Maddipati et al., 2014) . IL6 and IL1b can stimulate PGE 2 and PGF 2a production in gestational tissues such as myometrium, amnion and decidual cells (Mitchell et al., 1991; Keelan et al., 2003) . In the uterus, IL6 and IL1b also induce labor onset by up-regulating expression of UAPs in myometrium (Young et al., 1997; Fang et al., 2000; Rauk et al., 2001) . Our study demonstrated that PGF 2a administration triggered an up-regulation of IL6 and IL1b output in myometrial cells. Taken together, it may suggest that a positive interaction between PGF 2a and the pro-inflammatory cytokines IL1b and IL6 might occur within uterus, which amplifies inflammation and uterine activation as parturition is initiated. Both CXCL8 and CCL2 are responsible for the recruitment of monocytes, memory T cells and dendritic cells to sites of inflammation (Xu et al., 1996; Kobayashi, 2008; White et al., 2013) . CXCL8 is not only secreted from placental and decidual tissues (Saito et al., 1994; el Maradny et al., 1996; Denison et al., 1998 ) but higher expression is detected in myometrium at labor (Osmers et al., 1995) . CCL2 is also expressed in human myometrium and greatly increased after onset of labor (Esplin et al., 2005) . Our data indicate that PGF 2a significantly enhances CXCL8 and CCL2 production in HUSMCs which may suggest that PGF 2a is involved in the process of uterine activation at end of gestation.
In the present study, we found that, unlike IL1b and IL6, TNFa output was suppressed by PGF 2a in HUSMCs. It is hard to know the significance of PGF 2a inhibition of TNFa. Previous studies have investigated the expression of TNFa in relation to labor in a variety of gestational tissues with inconsistent results (Winkler et al., 2001; Tattersall et al., 2008; Thomakos et al., 2010; Alexander et al., 2012) . TNFa expression has been shown to be increased in amnion, chorion, and isolated choriodecidua with labor (Thomakos et al., 2010) . Some studies have reported that TNFa protein concentrations were low in decidua, fetal membranes, and myometrium, and that they did not change during the onset of labor (Winkler et al., 2001; Tattersall et al., 2008; You et al., 2014) . Given that TNFa can be induced by other pro-inflammatory cytokines such as IL1b and IL6, our findings that PGF 2a suppressed TNFa production in myometrium might partly explain why the expression of TNFa is not changed during labor even though the level of IL1b and IL6 is higher.
PTGFR, a member of the G-protein coupled receptor superfamily, principally couples to Gq protein leading to the activation of PLCb/ Ca 2+ /PKC signaling pathways. Our data indicate that PGF 2a modulation of chemokine and cytokine production is dependent on the PLC/PKC signaling pathway. It is known that Ca 2+ triggers calcineurin/NFAT signaling. PGF 2a up-regulates CXCL8 production via calcineurin/NFAT signaling pathway in endometrial cancer (Sales et al., 2009) . In the present study, we show that calcineurin/NFAT signaling pathway is involved in PGF 2a stimulation of CCL2 and suppression of TNFa, but not CXCL8 Figure 7 Scheme illustrating the signaling pathway involved in the production of chemokines and cytokines induced by prostaglandin F 2a (PGF 2a (Fig. 7) . Notably, the present study has shown that several kinase inhibitors themselves have corresponding effects on cytokine output, such as P38 inhibitor stimulated IL1b output while PDTC increased IL6 and CXCL8 output. Currently, it is unknown why these reagents increased secretion of the above cytokines. However, some studies have demonstrated the interaction between P38 and NF-kB signaling. Kanaji et al. (2012) have shown that P38 inhibitor enhances the level of phospho-p65 in endothelial cells, while PDTC has also been shown to induce P38 activation in vascular smooth muscle cells (Moon et al., 2004) . Interestingly, in the present study, we found that NF-kB activation leads to an increase in IL1b output while P38 signaling mediates PGF 2a stimulation of IL6 and CXCL8 output. Nevertheless, whether PDTC enhancing IL6 and CXCL8 output is through P38 signaling and P38 inhibitor increasing IL1b output is associated with NF-kB activation remains to be further elucidated.
Our previous study demonstrated that PGF 2a -induced changes in UAP abundance differ between US and LS HUMSCs (Xu et al., 2013) . Our findings that the response pattern of some cytokines to PGF 2a was different between LS and US cells confirm our earlier observation that the responsiveness to PGF 2a can vary between US and LS cells, and indicate potential differential roles of PGF 2a in US and LS during pregnancy and parturition. Although the mechanisms underlying different responsiveness to PGF 2a in US and LS are unknown, different PTGFR receptor densities in the two regions, different intracellular pathways, or the possibility that PGF 2a stimulates other mediators with varying effects in each region might attribute to the discrepancy of PGF 2a effects in US and LS.
In conclusion, our study systematically demonstrated that PGF 2a modulates chemokine and cytokine output in human pregnant myometrium no matter upper and lower segment. Multiple signaling pathways are involved in PGF 2a regulation of chemokine and cytokine output in myometrium. Our findings corroborate the hypothesis that the initiation and amplification of non-infectious inflammation is a positive feedback reaction. This complex interrelationship of PGs, cytokines and chemokines, activates the uterus and completes its transfer to a contractile state.
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